Company Filing History:
2 out of 8,373 
2 out of 18 Years Active: 1999
Title: The Innovative Contributions of Keith J. Johnson
Introduction: Keith J. Johnson is an esteemed inventor hailing from Glasgow, GB, known for his groundbreaking work in the field of genetics. With a total of two patents to his name, Keith's innovations focus on understanding and identifying genetic conditions, further advancing the field of molecular biology.
Latest Patents: Among his notable patents is the invention related to the "DNA sequence encoding the myotonic dystrophy gene and uses thereof." This invention addresses the CTG triplet repeat found in individuals affected by myotonic dystrophy. His innovative work enables the identification of individuals with normal copy numbers of the CTG triplet repeat, who are likely to be minimally affected, as well as those with abnormally high copy numbers who may face more severe symptoms. Furthermore, Keith's methods facilitate the detection of this genetic marker in samples, contributing significantly to the diagnosis and understanding of the disease.
Career Highlights: Throughout his career, Keith has made significant contributions while working at prestigious institutions such as the Massachusetts Institute of Technology and the University of Wales College of Medicine. His work not only showcases his deep understanding of genetic mechanisms but also underscores the importance of research in finding solutions to health-related challenges.
Collaborations: Collaboration has played a vital role in Keith's achievements. He has had the opportunity to work alongside esteemed colleagues, including J. David Brook and David E. Housman. These professional relationships have fostered an environment of shared knowledge and innovation, allowing for groundbreaking advancements in the understanding of myotonic dystrophy and related genetic conditions.
Conclusion: Keith J. Johnson's contributions to genetics reflect the spirit of innovation and dedication to improving human health. His patents have paved the way for better diagnostic methods for myotonic dystrophy, impacting many lives. As research in genetics continues to evolve, Keith's work remains a significant milestone in the field of molecular biology.